Danish pharma big Novo Nordisk teased promising early-phase trial benefits of its experimental weight loss tablet amycretin, sending the corporation’s stock surging.Soon after Novo Nordisk’s blockbuster weight loss drug Wegovy designed its debut in Asia by launching in Japan past thirty day period, the pharma company says it now expects the dru